Melatonin: Prescribing practices and adverse events [11]

Archives of Disease in Childhood

Volumn 90, Issue 11, 2005, Pages 1206-1207

  Waldron, D L ^a   Bramble, D ^b   Gringras, P ^c  

^a Harper House Children's Service   (United Kingdom)

^b Telford and Wrekin PCT   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

AGITATION; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; CLINICAL PRACTICE; CONSTIPATION; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DRUG INDICATION; DRUG USE; HUMAN; HYPERACTIVITY; LETTER; NIGHTMARE; PRESCRIPTION; PRIORITY JOURNAL; SEIZURE; SLEEP DISORDER;

CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; GREAT BRITAIN; HUMANS; MELATONIN; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 27644515078     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.077289     Document Type: Letter

References (4)

1. Willey C, Phillips B. Is melatonin likely to help children with neurodevelopmental disability and chronic severe sleep problems? Arch Dis Child 2002;87:260.
2. Jan JE, Freeman RD. Melatonin therapy of circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Dev Med Child Neurol 2004;46:776-82.
3. Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998;351:1254.
4. Palmer ME, Haller C, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study. Lancet 2003;361:101-6.